138 related articles for article (PubMed ID: 38748319)
1. Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses - a randomized, placebo-controlled clinical trial.
Eveleens Maarse BC; Ronner MN; Jansen MAA; Niemeyer-van der Kolk T; In 't Veld AE; Klaassen ES; Ahmad S; Itano A; McHale D; Moerland M
Immunol Res; 2024 May; ():. PubMed ID: 38748319
[TBL] [Abstract][Full Text] [Related]
2. Clinical translation of anti-inflammatory effects of
Itano A; Maslin D; Ramani K; Mehraei G; Carpenter N; Cormack T; Saghari M; Moerland M; Troy E; Caffry W; Wardwell-Scott L; Abel S; McHale D; Bodmer M
Front Med (Lausanne); 2023; 10():1070433. PubMed ID: 37215725
[TBL] [Abstract][Full Text] [Related]
3. Impact of oral administration of single strain
Saghari M; Gal P; Grievink HW; Klaassen ES; Itano A; McHale D; Moerland M
Front Immunol; 2022; 13():1009304. PubMed ID: 36582231
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of
Ehst BD; Strober B; Blauvelt A; Maslin D; Macaro D; Carpenter N; Bodmer M; McHale D
Front Med (Lausanne); 2024; 11():1292406. PubMed ID: 38813388
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Saghari M; Gal P; Ziagkos D; Burggraaf J; Powell JF; Brennan N; Rissmann R; van Doorn MBA; Moerland M
Br J Clin Pharmacol; 2021 Apr; 87(4):1953-1962. PubMed ID: 33025648
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.
Belson A; Schmidt T; Fernando D; Hardes K; Scott N; Brett S; Clark D; Oliveira JJ; Davis B; McHugh S; Stone J
Inflamm Res; 2016 May; 65(5):389-404. PubMed ID: 26969026
[TBL] [Abstract][Full Text] [Related]
7. Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Assil S; Buters TP; Hameeteman PW; Hallard C; Treijtel N; Niemeyer-Van der Kolk T; de Kam ML; Florencia EFIII; Prens EP; van Doorn MBA; Rissmann R; Klarenbeek NB; Jansen MAA; Moerland M
Front Immunol; 2023; 14():1197650. PubMed ID: 37545524
[TBL] [Abstract][Full Text] [Related]
8. T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans.
Spazierer D; Skvara H; Dawid M; Fallahi N; Gruber K; Rose K; Lloyd P; Heuerding S; Stingl G; Jung T
Clin Exp Allergy; 2009 Jul; 39(7):999-1008. PubMed ID: 19236409
[TBL] [Abstract][Full Text] [Related]
9. Modulation of systemic antigen-specific immune responses by oral antigen in humans.
Kapp K; Maul J; Hostmann A; Mundt P; Preiss JC; Wenzel A; Thiel A; Zeitz M; Ullrich R; Duchmann R
Eur J Immunol; 2010 Nov; 40(11):3128-37. PubMed ID: 20957752
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the adaptive immune response following immunization in pregnant sows (Sus scrofa) kept in two different housing systems.
Grün V; Schmucker S; Schalk C; Flauger B; Stefanski V
J Anim Sci; 2014 Aug; 92(8):3388-97. PubMed ID: 24948651
[TBL] [Abstract][Full Text] [Related]
11. Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production.
Connor TJ; Connelly DB; Kelly JP
Immunol Lett; 2001 Sep; 78(2):67-73. PubMed ID: 11672589
[TBL] [Abstract][Full Text] [Related]
12. Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.
Boelens PG; Fonk JC; Houdijk AP; Scheper RJ; Haarman HJ; Meijer S; Van Leeuwen PA; von Blomberg-van der Flier BM
Clin Exp Immunol; 2004 May; 136(2):356-64. PubMed ID: 15086402
[TBL] [Abstract][Full Text] [Related]
13. muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.
Lu IN; Kulkarni S; Fisk M; Kostapanos M; Banham-Hall E; Kadyan S; Bond S; Norton S; Cope A; Galloway J; Hall F; Jayne D; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):690. PubMed ID: 32736592
[TBL] [Abstract][Full Text] [Related]
14. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis.
Falcone M; Bloom BR
J Exp Med; 1997 Mar; 185(5):901-7. PubMed ID: 9120396
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen.
Akbar SM; Inaba K; Onji M
Immunology; 1996 Apr; 87(4):519-27. PubMed ID: 8675204
[TBL] [Abstract][Full Text] [Related]
16. OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M; Gal P; Gilbert S; Yateman M; Porter-Brown B; Brennan N; Quaratino S; Wilson R; Grievink HW; Klaassen ES; Bergmann KR; Burggraaf J; van Doorn MBA; Powell J; Moerland M; Rissmann R
Clin Pharmacol Ther; 2022 May; 111(5):1121-1132. PubMed ID: 35092305
[TBL] [Abstract][Full Text] [Related]
17. A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.
Ferbas J; Belouski SS; Horner M; Kaliyaperumal A; Chen L; Boyce M; Colaço CB; McHugh N; Quick V; Nicholl RJ; Siu G; Chung J
Br J Clin Pharmacol; 2013 Aug; 76(2):188-202. PubMed ID: 23731388
[TBL] [Abstract][Full Text] [Related]
18. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.
Thatcher TH; Luzina I; Fishelevich R; Tomai MA; Miller RL; Gaspari AA
J Invest Dermatol; 2006 Apr; 126(4):821-31. PubMed ID: 16439962
[TBL] [Abstract][Full Text] [Related]
19. Keyhole limpet haemocyanin in experimental bladder cancer: literature review and own results.
Linn JF; Black P; Derksen K; Rübben H; Thüroff JW
Eur Urol; 2000; 37 Suppl 3():34-40. PubMed ID: 10828685
[TBL] [Abstract][Full Text] [Related]
20. Interferon and Toll-Like Receptor 7 Response in COVID-19: Implications of Topical Imiquimod for Prophylaxis and Treatment.
Szeto MD; Maghfour J; Sivesind TE; Anderson J; Olayinka JT; Mamo A; Runion TM; Dellavalle RP
Dermatology; 2021; 237(6):847-856. PubMed ID: 34511591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
